医疗器械行业
多发性硬化症(MS)新药!中枢神经系统共价BTK抑制剂evobrutinib:经过3.5年的治疗 它显示出持久的临床效益!
(2022-10-31)- (2022-10-31)
- (2022-10-31)
- (2022-10-31)
- (2022-10-31)
- (2022-10-29)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-28)
- (2022-10-27)
- (2022-10-27)
- (2022-10-27)
- (2022-10-27)
- (2022-10-27)
- (2022-10-27)
- (2022-10-27)
- (2022-10-26)
- (2022-10-26)
- (2022-10-26)
- (2022-10-26)
- (2022-10-26)
- (2022-10-25)
- (2022-10-25)
- (2022-10-25)
- (2022-10-25)
- (2022-10-25)
- (2022-10-25)
- (2022-10-25)
- (2022-10-24)
- (2022-10-24)
- (2022-10-24)
- (2022-10-24)
- (2022-10-24)
- (2022-10-24)
- (2022-10-24)
- (2022-10-21)
- (2022-10-20)
- (2022-10-20)
- (2022-10-20)
- (2022-10-20)
- (2022-10-20)
- (2022-10-20)
- (2022-10-20)
- (2022-10-20)
- (2022-10-20)
- (2022-10-20)
- (2022-10-19)
- (2022-10-19)
- (2022-10-19)
- (2022-10-19)